1.Comparative evaluation of the antioxidant capacity of crocetin and crocin in vivo
Yang CHEN ; Ting YANG ; Juan HUANG ; Xi TIAN ; Can ZHAO ; Le CAI ; Lijuan FENG ; Hao ZHANG
Chinese Pharmacological Bulletin 2010;26(2):248-251
Aim To investigate the antioxidant capacity of crocetin and crocin in an in vivo system.Methods Column chromatography was applied to the seperation of crocetin and crocin-1 from gardenia.Crocetin(6.25,12.5 and 25.0 mg·kg~(-1)·d~(-1)) and crocin (18.7,37.5 and 75.0 mg·kg~(-1)·d~(-1)) were orally administered to kunming mice.Then,superoxide dismutase(SOD),glutathione peroxidase(GSH-Px),total antioxidant capacity(TAOC)and malondialdehyde(MDA)in mice were determined for the comparison of antioxidant activity of crocetin and crocin-1.Results Oral administration of crocetin and crocin for six weeks could enhance SOD of liver and kidney,GSH-Px of liver and TAOC of heart and kidney.In addition,it could decrease MDA of serum in mice.Conclusions The comparison of results suggests the evidence supporting the comparable antioxidant activity of crocetin and crocin.The results of the research also indicate that liver and kidney are two organs targeted for protection concerning endogenous antioxidant among various tissues.
2.Smart healthcare: making medical care more intelligent
Shuo TIAN ; Wenbo YANG ; Jehane Michael Le Grange ; Peng WANG ; Wei HUANG ; Zhewei YE
Global Health Journal 2019;3(3):62-65
With the development of information technology,the concept of smart healthcare has gradually come to the fore.Smart healthcare uses a new generation of information technologies,such as the internet of things (IoT),big data,cloud computing,and artificial intelligence,to transform the traditional medical system in an all-round way,making healthcare more efficient,more convenient,and more personalized.With the aim of introducing the concept of smart healthcare,in this review,we first list the key technologies that support smart healthcare and introduce the current status of smart healthcare in several important fields.Then we expound the existing problems with smart healthcare and try to propose solutions to them.Finally,we look ahead and evaluate the future prospects of smart healthcare.
3.Research progress of natural product evodiamine-based antitumor drug design strategies
Zhe-wei XIA ; Yu-hang SUN ; Tian-le HUANG ; Hua SUN ; Yu-ping CHEN ; Chun-quan SHENG ; Shan-chao WU
Acta Pharmaceutica Sinica 2024;59(3):532-542
Natural products are important sources for the discovery of anti-tumor drugs. Evodiamine is the main alkaloid component of the traditional Chinese herb Wu-Chu-Yu, and it has weak antitumor activity. In recent years, a number of highly active antitumor candidates have been discovered with a significant progress. This article reviews the research progress of evodiamine-based antitumor drug design strategies, in order to provide reference for the development of new drugs with natural products as leads.
4.Clinical trial of progesterone combined with nifedipine in the treatment of upper ureteral calculi
Se-Lan HUANG ; Yan-Le YE ; Yi-Tian SHEN
The Chinese Journal of Clinical Pharmacology 2017;33(7):592-594
Objective To evaluate the clinical efficacy and safety of progesterone combined with nifedipine in the treatment of upper ureteral calculi.Methods A total of 94 patients with upper ureteral calculi werc divided into control group and treatment group,47 cases in cach group.Patients in control group were given anisodamine hydrochloride injection 5-10 mg by intramuscular injection,qd.Patients in treatment group received progesterone injection 20 mg by intramuscular injection,bid and nifedipine tablets 10 mg by under tongue,tid.All patients were treated for 14 d.The clinical efficacy,C-reactive protein(CRP),interleukin-6 (IL-6) and adverse drug reactions were compared between the two groups.Results The clinical efficacy in treatment group was 95.74% (45/47 cases),had significant difference with that in control group,which was 82.98% (39/47 cases,P <0.05).The levels of CRP and IL-6 in treatment group were (2.17 ± 0.25) mg · L-1,(4.72 ± 0.51) ng · L-1,had significant difference with those in control group,which were(3.45 ±0.42) mg· L-1,(8.34±0.89) ng · L-1 (P <0.05).The main adverse drug reactions in treatment group were dry mouth,blurred vision and rashes,the incidence rate was 6.38% (3/47 cases).The main adverse drug reactions were dry mouth,rapid heart beat,difficulty urinating and rashes in control group,the incidence rate was 10.64% (5/47 cases,P > O.05).Conclusion Progesterone combined with nifedipine in the treatment of upper ureteral calculi was effective with high safety.
5.Prevalence and influencing factors of post-stroke depression among middle aged and elderly stroke patients in Mongolia and Han nationality
Na GAO ; Tian LAN ; Yan SHE ; Hu Bao Li Ge ; Qi Le Mu Ge ; Go Ri SU ; Kairong HUANG ; Xuefei YAO ; Hu Ri Le Te Mu Er
Chinese Journal of Behavioral Medicine and Brain Science 2018;27(4):366-371
Objective To explore the prevalence and analyze the related risk factors for post-stroke depression among middle-aged and elderly stroke patients of Mongolia and Han nationality in Inner Mongolia Autonomous Region.Methods A stratified multistage random cluster sampling method was used to investigate the prevalence of stroke in the population aged ≥45 years in different areas of Inner Mongolia Autonomous Region.A total of 11 088 people were investigated and 498 were stroke patients among them.A set of scale assessment and the general situation were used to investigate stroke patients and 443 patients completed the whole survey.Results The total prevalence of post-stroke depression (PSD) was 41.08% in 443 stroke patients,among which the prevalence rate was 40.57% for Mongolian population and 41.85% for Han population,and no significant difference was found between Mongolian and Han nationality(x2=1.372,P=0.504).There were significant differences in the types of stroke between the Mongolian and Han nationality (x2 =7.347,P=0.025).The age (t=4.321,P=0.000),educational level (x2 =27.036,P=0.001) and economic burden (x2=27.877,P=0.000) were statistically significant between Mongolian and Han nationality.The differences of frequency of stroke (x2 =6.545,P=0.011),economic burden (x2 =16.148,P=0.001),cognitive dysfunction (x2 =9.065,P=0.003),daily living ability (x2 =34.466,P =0.000),alcohol consumption history(x2=4.516,P=0.034)were statistically significant.Logistic regression analysis showed that alcohol consumption history,economic burden,the frequency of stroke,and cognitive dysfunction were the influencing factors of PSD.Conclusion PSD is one of the important factors affecting the post-stroke psychological burden in Inner Mongolia Autonomous Region.There is no national difference in the prevalence of PSD among Mongolian and Han people,which provides a theoretical basis for the treatment and intervention of PSD.
6.Lactobacillus rhamnosus GG conditioned medium prevents E. coli meningitis by inhibiting nuclear factor-κB pathway.
Qing ZENG ; Xiao-Long HE ; Han-Sheng XIAO ; Lei DU ; Yu-Jing LI ; Le-Cheng CHEN ; Hui-Wen TIAN ; Sheng-He HUANG ; Hong CAO
Journal of Southern Medical University 2017;37(1):24-29
OBJECTIVETo investigate whether Lactobacillus rhamnosus GG conditioned medium(LGG-CM)has preventive effect against E. coli K1-induced neuropathogenicity in vitro by inhibiting nuclear factor-κB (NF-κB) signaling pathway.
METHODSAn in vitro blood-brain barrier (BBB) model was constructed using human brain microvascular endothelial cells (HBMECs). The effect of LGG-CM on E. coli-actived NF-κB signaling pathway was assayed using Western blotting. Invasion assay and polymorphonuclear leukocyte (PMN) transmigration assay were performed to explore whether LGG-CM could inhibit E. coli invasion and PMN transmigration across the BBB in vitro. The expressions of ZO-1 and CD44 were detected using Western blotting and immunofluorescence. The changes of trans-epithelial electric resistance (TEER) and bacterial translocation were determined to evaluate the BBB permeability.
RESULTSPre-treament with LGG-CM inhibited E. coli-activated NF-κB signaling pathway in HBMECs and decreased the invasion of E. coli K1 and transmigration of PMN. Western blotting showed that LGG-CM could alleviate E. coli-induced up-regulation of CD44 and down-regulation of ZO-1 expressions in HBMECs. In addition, pre-treatment with LGG-CM alleviated E. coli K1-induced reduction of TEER and suppressed bacterial translocation across the BBB in vitro.
CONCLUSIONLGG-CM can block E. coli-induced activation of NF-κB signaling pathway and thereby prevents E. coli K1-induced neuropathogenicity by decreasing E. coli K1 invasion rates and PMN transmigration.
7.Three-dimensional low-dose CT volume reconstruction based on non-local weights optimization and GPU acceleration.
Xi-le ZHANG ; Ling-ling TIAN ; Jing HUANG ; Jian-hua MA ; Hua ZHANG ; Qian-jin FENG ; Wu-fan CHEN
Journal of Southern Medical University 2011;31(12):1974-1980
Concerns have been raised over x-ray radiation dose associated with repeated computed tomography (CT) scans for tumor surveillance and radiotherapy planning. In this paper, we present a low-dose CT image reconstruction method for improving low-dose CT image quality. The method proposed exploited rich redundancy information from previous normal-dose scan image for optimizing the non-local weights construction in the original non-local means (NLM)-based low-dose image reconstruction. The objective 3D low-dose volume and the previous 3D normal-dose volume were first registered to reduce the anatomic structural dissimilarity between the two datasets, and the optimized non-local weights were constructed based on the registered normal-dose volume. To increase the efficiency of this method, GPU was utilized to accelerate the implementation. The experimental results showed that this method obviously improved the image quality, as compared with the original NLM method, by suppressing the noise-induced artifacts and preserving the edge information.
Algorithms
;
Artifacts
;
Humans
;
Imaging, Three-Dimensional
;
methods
;
Phantoms, Imaging
;
Radiation Dosage
;
Radiation Protection
;
standards
;
Radiographic Image Interpretation, Computer-Assisted
;
methods
;
standards
;
Tomography, X-Ray Computed
;
methods
8.Autologous peripheral blood CD34+ stem cells transplanted into 100 patients with advanced cirrhosis.
Yutong YAO ; Lanyun LUO ; Hua XUE ; Le LUO ; Haibo ZOU ; Guan WANG ; Zhiming AN ; Ming ZHONG ; Xiaobing HUANG ; Yifan ZHU ; Lingling WEI ; Maozhu YANG ; Tian ZHANG ; Ping XIE ; Gang XU ; Shaoping DENG ; Xiaolun HUANG
Chinese Journal of Hepatology 2014;22(9):667-670
OBJECTIVETo investigate whether transplantation of autologous peripheral blood CD34+ stem cells is a viable approach for treating patients with advanced cirrhosis,which is currently hindered by a shortage in liver donors.
METHODSA total of 100 patients with advanced cirrhosis and who had failed to respond to conservative therapy were recruited for transplantation of autologous peripheral blood CD34+ stem cells.The success of transplantation was investigated 6-and 12-months later by measuring markers of liver biosynthesis function (coagulation,albumin level,indocyanine green clearance,Child-Pugh score) and assessing pathological changes (Knodell score) and morphologic changes in the liver tissue.Complications were also recorded during follow-up.
RESULTSThe 1-year cumulative survival rate was 100%. Fifty-two patients with massive ascites showed gradual reduction and disappearance of the ascites.Four patients experienced upper gastrointestinal bleeding and three patients developed with hepatic encephalopathy (I-II degree) at 3 months post-transplantation.All patients showed significantly improved liver biosynthesis function,liver elasticity and Knodell score after transplantation (P less than 0.05).
CONCLUSIONAutologous peripheral blood CD34+ stem cell transplantation is a safe and effective treatment for advanced cirrhosis,and has high cost-benefit since it improves liver function,liver histology,and quality of life.
Ascites ; Humans ; Liver Cirrhosis ; therapy ; Quality of Life ; Stem Cell Transplantation ; Transplantation, Autologous ; Treatment Outcome
9.Clinical Outcome of Autologous Hematopoietic Stem Cell Infusion via Hepatic Artery or Portal Vein in Patients with End-stage Liver Diseases
Huang XIAO-LUN ; Luo LE ; Luo LAN-YUN ; Xue HUA ; Wei LING-LING ; Yao YU-TONG ; Zou HAI-BO ; Huang XIAO-BING ; Zhu YI-FAN ; Zhang TIAN ; Xie PING ; Yang MAO-ZHU ; Deng SHAO-PING
Chinese Medical Sciences Journal 2014;(1):15-22
Objective To investigate the efficacy of hematopoietic stem cell (HSC) transplantation via the hepatic artery vs. the portal vein for end-stage liver disease (ESLD).
Methods Patients with hepatic decompensation were prospectively recruited from September 2010 to September 2012 to receive HSC transplantation via the hepatic artery or the portal vein. Liver function was examined at 3, 6, and 12 months after transplantation. Liver biopsy results were analyzed using the Knodell score.
Results Eighty patients (58 males and 22 females) were enrolled in the study. The Child-Pugh score was grade B in 69 cases, and grade C in the remaining 11 cases. HSC transplantation was performed via the portal vein in 36 patients and via the hepatic artery in 44 patients. ALT levels decreased while serum albumin levels increased significantly in both groups at 6 and 12 months after HSC transplantation (P<0.05 compared with pre-transplantation levels). Total bilirubin levels decreased significantly in both groups at 3, 6, and 12 months after HSC transplantation (P<0.05 compared with pre-transplantation levels). Additionally, prothrombin time decreased in both groups at 12 months after HSC transplantation (P<0.05 compared with pre-transplantation level). There were no significant differences in ALT, total bilirubin and prothrombin time between the two groups either before or after transplantation. Moreover, Knodell score decreased significantly at 6 and 12 months. Histological examination showed that liver cell edema, degeneration, necrosis, and inflammation were significantly relieved at 3, 6, and 12 months after transplantation. The incidence of portal vein thrombosis, upper gastrointestinal bleeding, and hepatic encephalopathy were 1.25%, 3.75%, and 2.5%respectively.The one-year survival rate was 100%.
Conclusions Autologous HSC transplantation improves liver function and histology in ESLD patients. The administration route of HSC has no significant impact on the efficacy of transplantation.
10.A clinical study on the treatment of postherpetic neuralgia with pulsed radiofrequency of the dorsal root ganglion with pain management
Zhi-Hong Xiong ; Xue-Fang Tang ; Le-Tian Huang ; Li-Rong Yue ; ZH Xiong ; XF Tang
Neurology Asia 2020;25(3):313-317
This study aimed to investigate the clinical efficacy of pulsed radiofrequency (PRF) of the dorsal
root ganglion (DRG) with pain management as treatment of post-herpetic neuralgia (PHN). A total
of 78 patients with PHN in the thoracolumbar region were randomly divided into two groups (n = 39
for each group): Group A, oral drug treatment only; Group B, DRG PRF of the thoracic spinal nerve
combined with oral drug treatment. The numerical rating scale (NRS) scores of both groups were
observed before treatment and at 1, 4, 8, and 12 weeks after treatment. The results showed that the
NRS scores of both groups were significantly decreased after treatment (P < 0.05). In addition, the
NRS score in Group B decreased significantly more than in Group A (P < 0.05). In conclusion, DRG
PRF with pain management is a safe and effective treatment for elderly PHN patients, and it can
quickly alleviate pain symptoms.